PriceWatch: U.S. Cost of Insulin Nearly Triples from 2012 to 2016

Jan 23, 2019 | Insulin, Pharmaceutical, Price Watch, Pricing


Reuters reported that the cost of insulin for treating type 1 diabetes in the U.S. has nearly doubled over a five-period according to a new analysis by nonprofit Health Care Cost Institute (HCCI). Reuters noted that the increases are putting some patients at risk. The price for one person with type 1 diabetes has grown rom $2,864 in 2012 to $5,705 in 2016. TrialSite News has written about consequential lawsuits. For example the State of Minnesota is suing Novo Nordisk, Eli Lilly and Sanofi for deceptive pricing.


Pin It on Pinterest